Stay updated on SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial
Sign up to get notified when there's something new on the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page.

Latest updates to the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check43 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference2%
- Check51 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check65 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check72 days agoChange DetectedThe website has been updated to version 2.14.0, adding a new contact for intervention inquiries and removing the previous version's intervention type.SummaryDifference0.6%
- Check101 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
Stay in the know with updates to SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page.